MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
841.72%
Quick Ratio
841.72%
Cash Ratio
193.56%
Debt to Asset Ratio
11.55%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Long-term investments
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other curre...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
78,640
75,081
88,332
103,335
Short-term investments
255,898
276,804
289,564
229,261
Prepaid expenses and other current assets
7,436
9,522
8,860
9,639
Total current assets
341,974
361,407
386,756
342,235
Total property and equipment, gross
-
-
1,390
-
Less accumulated depreciation
-
-
969
-
Property and equipment, net
263
342
421
489
Operating lease right-of-use assets
2,233
2,437
2,630
1,046
Other assets
297
297
297
361
Long-term investments
19,020
38,501
58,270
139,995
Total assets
363,787
402,984
448,374
484,126
Accounts payable
3,725
2,509
841
1,722
Accrued expenses and other current liabilities
36,237
31,920
36,120
29,847
Operating lease liabilities, current
666
725
780
1,188
Total current liabilities
40,628
35,154
37,741
32,757
Operating lease liabilities, net of current portion
1,405
1,658
1,903
0
Total liabilities
42,033
36,812
39,644
32,757
Common stock, 0.0001 par value, 150,000,000 shares authorized as of june 30, 2026 and december 31, 2025 64,345,770 and 60,244,136 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
6
-
6
6
Additional paid-in capital
1,013,366
-
995,823
987,796
Accumulated other comprehensive income (loss)
-134
-
1,020
973
Accumulated deficit
-691,484
-
-588,119
-537,406
Total cullinan stockholders' equity
321,754
-
408,730
451,369
Noncontrolling interests
-
-
0
0
Total stockholders' equity
321,754
366,172
408,730
451,369
Total liabilities and stockholders' equity
363,787
402,984
448,374
484,126
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$255,898K (32.82%↑ Y/Y)Cash and cashequivalents$78,640K (7.99%↑ Y/Y)Prepaid expenses andother current assets$7,436K (-28.70%↓ Y/Y)Total current assets$341,974K (23.94%↑ Y/Y)Long-term investments$19,020K (-92.15%↓ Y/Y)Operating leaseright-of-use assets$2,233K (89.24%↑ Y/Y)Other assets$297K (-19.07%↓ Y/Y)Property and equipment,net$263K (-53.78%↓ Y/Y)Total assets$363,787K (-30.09%↓ Y/Y)Total liabilities andstockholders' equity$363,787K (-30.09%↓ Y/Y)Total stockholders'equity$321,754K (-34.62%↓ Y/Y)Total liabilities$42,033K (49.14%↑ Y/Y)Total cullinanstockholders' equity$321,754K (-34.62%↓ Y/Y)Total currentliabilities$40,628K (44.80%↑ Y/Y)Operating leaseliabilities, net of current...$1,405K (1024.00%↑ Y/Y)Accumulated deficit-$691,484K (-42.05%↓ Y/Y)Accumulated othercomprehensive income (loss)-$134K (-122.08%↓ Y/Y)Additional paid-in capital$1,013,366K (3.58%↑ Y/Y)Accrued expenses andother current...$36,237K (49.72%↑ Y/Y)Accounts payable$3,725K (51.36%↑ Y/Y)Operating leaseliabilities, current$666K (-52.22%↓ Y/Y)Common stock, 0.0001par value,...$6K (0.00%↑ Y/Y)

Cullinan Therapeutics, Inc. (CGEM)

Cullinan Therapeutics, Inc. (CGEM)